Showing results (561-570 of 1,005) with videos related to
Sort By:
Pageof 101
Chronic Illness|May 7, 2020
A randomized controlled trial of high-intensity interval training and inspiratory muscle training for chronic heart failure patients with inspiratory muscle weaknessZahra Sadek, Ali Salami, Mahmoud Youness, et al.Melanoma Research|May 31, 2021
C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant settingJustine Lauwyck, Aline Beckwée, Arno Santens, et al.Acta Gastro-Enterologica Belgica|February 10, 2009
Concomitant chemo-radiotherapy as standard therapy in limited-stage small-cell oesophageal cancer: a summary of 3 clinical cases and review of the literatureBertrand Vos, Julien Gallez, Sébastien Debroux, et al.Vaccines|September 23, 2022
Variations in COVID-19 Vaccine Attitudes and Acceptance among Refugees and Lebanese Nationals Pre- and Post-Vaccine Rollout in LebanonZawar Ali, Shiromi M Perera, Stephanie C Garbern, et al.Therapeutic Advances in Medical Oncology|July 12, 2023
Antibody-drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatmentGuilherme Nader-Marta, Chiara Molinelli, Véronique Debien, et al.Frontiers in Plant Science|May 6, 2024
Stress phenotyping analysis leveraging autofluorescence image sequences with machine learningSruti Das Choudhury, Carmela Rosaria Guadagno, Srinidhi Bashyam, et al.Pediatric Gastroenterology, Hepatology & Nutrition|July 28, 2021
Prevalence, Laboratory Findings and Clinical Characteristics of Campylobacteriosis Agents among Hospitalized Children with Acute Gastroenteritis in LebanonGhassan Ghssein, Rana Awada, Ali Salami, et al.Building and Environment|October 26, 2021
Occupant health in buildings: Impact of the COVID-19 pandemic on the opinions of building professionals and implications on researchMohamad Awada, Burçin Becerik-Gerber, Elizabeth White, et al.Cells|July 29, 2023
Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted TherapiesAhmad Najem, Mohammad Krayem, Serena Sabbah, et al.ESMO Open|January 14, 2023
Challenges and knowledge gaps with immune checkpoint inhibitors monotherapy in the management of patients with non-small-cell lung cancer: a survey of oncologist perceptionsL Castelo-Branco, G Morgan, A Prelaj, et al.Pageof 101